The role of Vasoactive Intestinal Peptide (VIP) in megakaryocyte proliferation

Journal of Molecular Neuroscience

Volumn 37, Issue 2, 2009, Pages 160-167

  Nam, Chaneun ^a   Case, Adam J ^a   Hostager, Bruce S ^a   O'Dorisio, M Sue ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

CMK; Megakaryocyte; Platelet; Vasoactive intestinal peptide (VIP); Vasoactive intestinal peptide receptor type 1 (VPAC1)

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; AUTOCRINE EFFECT; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; THROMBOCYTOPOIESIS; TRANSGENE; ACUTE MEGAKARYOCYTIC LEUKEMIA; CELL DIVISION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION;

AUTOCRINE COMMUNICATION; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MEGAKARYOCYTES; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 61549125400     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9119-x     Document Type: Article

References (33)

1. D. A. Balster M. S. O'Dorisio A. R. Albers S. K. Park S. J. Qualman 2002 Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1 Regulatory Peptides 109 155 165 12409228 10.1016/S0167-0115(02)00199-4 1:CAS:528:DC%2BD38Xot1Wrtb4%3D (Pubitemid 35292407)
2. E. M. Battinelli J. H. Hartwig J. E. Italiano Jr. 2007 Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis Current Opinion in Hematology 14 419 426 17934346 10.1097/MOH.0b013e3282bad151 (Pubitemid 47457630)
3. E. S. Choi J. L. Nichol M. M. Hokom A. C. Hornkohl P. Hunt 1995 Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional Blood 85 402 413 7529062 1:CAS:528:DyaK2MXjtVWiurw%3D
4. N. Ercal M. S. O'Dorisio A. Vinik T. M. O'Dorisio M. Kadrofske 1988 Vasoactive intestinal peptide and related peptides. Vasoactive intestinal peptide receptors in human platelet membrane: Characterization of binding and functional assay Annals of the New York Academy of Sciences 527 1 663 691 10.1111/j.1749-6632.1988.tb27036.x (Pubitemid 18215234)
5. K. Freson H. Hashimoto C. Thys C. Wittevrongel S. Danloy Y. Morita, et al. 2004 The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation The Journal of Clinical Investigation 113 905 912 15067323 1:CAS:528:DC%2BD2cXisVagtbY%3D
6. K. Freson K. Peeters V. R. De C. Wittevrongel C. Thys M. F. Hoylaerts, et al. 2008 PACAP and its receptor VPAC1 regulate megakaryocyte maturation: Therapeutic implications Blood 111 1885 1893 18000164 10.1182/blood-2007-06- 098558 1:CAS:528:DC%2BD1cXisVeis78%3D
7. E. J. Goetzl 2006 Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes Regulatory Peptides 137 75 78 16934888 10.1016/j.regpep.2006.04.022 1:CAS:528:DC%2BD28Xht1ersrrE (Pubitemid 44755482)
8. A. J. Harmar A. Arimura I. Gozes L. Journot M. Laburthe J. R. Pisegna, et al. 1998 International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide Pharmacological Reviews 50 265 270 9647867 1:CAS:528: DyaK1cXksFCltr4%3D (Pubitemid 28304027)
9. J. E. Italiano Jr. S. Patel-Hett J. H. Hartwig 2007 Mechanics of proplatelet elaboration Journal of Thrombosis and Haemostasis 5 Suppl 1 18 23 17635704 10.1111/j.1538-7836.2007.02487.x 1:CAS:528:DC%2BD2sXovFGltrY%3D (Pubitemid 46958812)
10. M. Jonsson O. Norrgard M. Hansson S. Forsgren 2007 Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis Annals of the New York Academy of Sciences 1107 280 289 17804556 10.1196/annals.1381.030 (Pubitemid 47528805)
11. K. Kaushansky 2008 Historical review: Megakaryopoiesis and thrombopoiesis Blood 111 981 986 18223171 10.1182/blood-2007-05-088500 1:CAS:528: DC%2BD1cXhvFejsL8%3D (Pubitemid 351213374)
12. H. Kimata A. Yoshida C. Ishioka M. Fujimoto K. Furusho 1996 Vasoactive intestinal peptide enhances immunoglobulin production and growth in human plasma cells via mechanisms that may involve protein kinase C The Journal of Clinical Endocrinology and Metabolism 81 3024 3032 8768869 10.1210/jc.81.8.3024 1:CAS:528:DyaK28XkvFWqsbY%3D (Pubitemid 26323903)
13. M. Laburthe A. Couvineau J.-C. Marie 2002 VPAC receptors for VIP and PACAP Receptors and Channels 8 137 153 12529932 10.1080/10606820213680 1:CAS:528:DC%2BD38XnsFemt7k%3D
14. M. Lara-Marquez M. O'Dorisio T. O'Dorisio M. Shah B. Karacay 2001 Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells Journal of Immunology 166 2522 2530 1:CAS:528:DC%2BD3MXht1Giurc%3D
15. R. M. Leven 2004 Isolation of primary megakaryocytes and studies of proplatelet formation Methods in Molecular Biology 272 281 291 15226551
16. M. A. Lichtman J. K. Chamberlain W. Simon P. A. Santillo 1978 Parasinusoidal location of megakaryocytes in marrow: A determinant of platelet release American Journal of Hematology 4 303 312 717392 10.1002/ajh.2830040402 1:STN:280:CSaD2MblvFc%3D
17. S. K. Park T. A. Olson N. Ercal M. Summers M. S. O'Dorisio 1996 Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets Blood 87 4629 4635 8639831 1:CAS:528: DyaK28Xjt1equrY%3D
18. V. Petkov W. Mosgoeller R. Ziesche M. Raderer L. Stiebellehner K. Vonbank, et al. 2003 Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension The Journal of Clinical Investigation 111 1339 1346 12727925 1:CAS:528:DC%2BD3sXjsFCrsrs%3D
19. J. B. Regard H. Kataoka D. A. Cano E. Camerer L. Yin Y. W. Zheng, et al. 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion The Journal of Clinical Investigation 117 4034 4043 17992256 1:CAS:528:DC%2BD2sXhsValsL3M
20. S. I. Said 2007 The discovery of VIP: Initially looked for in the lung, isolated from intestine, and identified as a neuropeptide Peptides 28 1620 1621 17719695 10.1016/j.peptides.2007.06.007 1:CAS:528:DC%2BD2sXhtVWms7jL (Pubitemid 47361430)
21. B. Schmitz A. Radbruch T. Kummel C. Wickenhauser H. Korb M. L. Hansmann, et al. 1994 Magnetic activated cell sorting (MACS)-A new immunomagnetic method for megakaryocytic cell isolation: comparison of different separation techniques European Journal of Haematology 52 267 275 8020626 1:STN:280:ByuB1M7otVA%3D
22. G. Scurfield J. M. Radley 1981 Aspects of platelet formation and release American Journal of Hematology 10 285 296 7246536 10.1002/ajh.2830100308 1:STN:280:Bi6B38bkslA%3D (Pubitemid 11104961)
23. T. P. Segerson K. S. Lam L. Cacicedo N. Minamitani J. S. Fink R. M. Lechan, et al. 1989 Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland Endocrinology 725 2221 2223
24. J. S. Stamler J. Loscalzo 1992 Capillary zone electrophoretic detection of biological thiols and their S-nitrosated derivatives Analytical Chemistry 64 779 785 1524223 10.1021/ac00031a014 1:CAS:528:DyaK38XhsVOgsbs%3D
25. M. A. Summers M. S. O'Dorisio M. O. Cox M. Lara-Marquez E. Goetzl 2003 A lymphocyte generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects The Journal of Pharmacology and Experimental Therapeutics 306 638 645 12750439 10.1124/jpet.103.050583 1:CAS:528:DC%2BD3sXlslGlurs%3D (Pubitemid 36886163)
26. F. Tablin M. Castro R. M. Leven 1990 Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation Journal of Cell Science 97 Pt 1 59 70 1979559
27. M. Tavassoli M. Aoki 1989 Localization of megakaryocytes in the bone marrow Blood Cells 15 3 14 2649185 1:STN:280:BiaC1MvktFY%3D
28. K. S. Topp F. Tablin J. Levin 1990 Culture of isolated bovine megakaryocytes on reconstituted basement membrane matrix leads to proplatelet process formation Blood 76 912 924 2393717 1:STN:280:By%2BA28nmvFE%3D
29. C. Van Geet 2004 Thrombopoiesis: New concepts Verhandelingen-Koninklijke Academie voor Geneeskunde van België 66 5 24 15074080
30. N. Vitrat K. Cohen-Solal F. Norol J. Guichard E. Cramer W. Vainchenker, et al. 1998 Compared effects of Mpl ligand and other cytokines on human MK differentiation Stem Cells 16 Suppl 2 37 51 11012176
31. A. M. Vosko A. Schroeder D. H. Loh C. S. Colwell 2007 Vasoactive intestinal peptide and the mammalian circadian system General and Comparative Endocrinology 152 165 175 17572414 10.1016/j.ygcen.2007.04.018 1:CAS:528:DC%2BD2sXmvV2iu7g%3D (Pubitemid 46935157)
32. Y. Wang Y. Mei S. Bao L. Xu 2007 Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses Clinical and Experimental Immunology 148 178 187 17349016 1:CAS:528: DC%2BD2sXlt1Grsbo%3D
33. G. Zauli A. Bassini M. Vitale D. Gibellini C. Celeghini E. Caramelli, et al. 1997 Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase Blood 89 883 895 9028319 1:CAS:528:DyaK2sXptVKnug%3D%3D